$DRTX News 7 Biotechnology Stocks to Buy Now 6:3
Post# of 145216
Posted On: 12/12/2013 11:09:19 AM
$DRTX News
7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
UPDATE: Wedbush Downgrades Durata Therapeutics as CBST/Hospira Litigation Overhang Looms 9:20 a.m. Dec. 2, 2013 - benzinga.com
Wedbush downgrades Durata Therapeutics to Neutral 8:02 a.m. Dec. 2, 2013 - Seeking Alpha
Durata Therapeutics (DRTX) in Focus: Stock Up 7.9% - Tale of the Tape 8:44 a.m. Nov. 29, 2013 - Zacks.com
2014 FDA Drug Approval Decision Calendar 8:00 a.m. Nov. 27, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:05 p.m. Nov. 22, 2013 - TheStreet.com
9 Biotechnology Stocks to Buy Now 6:45 a.m. Nov. 20, 2013 - InvestorPlace.com
UPDATE: Janney Capital Markets Initiates Coverage on Durata Therapeutics on Fundamentally Changing Antibiotic Treatment 7:38 a.m. Nov. 13, 2013 - benzinga.com
10-Q: DURATA THERAPEUTICS, INC. 6:47 a.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
8 Biotechnology Stocks to Sell Now 5:30 a.m. Oct. 3, 2013 - InvestorPlace.com
Durata Data on Dalbavancin Shows Primary Endpoints Met 5:33 a.m. Oct. 2, 2013 - benzinga.com
Durata Therapeutics Inc (DRTX) Enters Overbought Territory - Tale of the Tape 7:01 a.m. Sept. 12, 2013 - Zacks.com
10 Biotechnology Stocks to Sell Now 4:45 a.m. Sept. 4, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Sell Now 2:30 a.m. Aug. 21, 2013 - InvestorPlace.com
10-Q: DURATA THERAPEUTICS, INC. 7:08 a.m. Aug. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Durata Therapeutics' Novel Antibiotic Makes It A Prime Takeover For 2013 6:25 p.m. July 30, 2013 - Seeking Alpha
Buying Opportunity In Durata Therapeutics 12:04 p.m. June 28, 2013 - Seeking Alpha
10-Q: DURATA THERAPEUTICS, INC. 7:09 a.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Durata Announces Data from Phase I Trial of Dalbavancin 5:35 a.m. April 29, 2013 - benzinga.com
UPDATE: Wedbush Lowers PT on Durata Therapeutics on Revised 2013 Total Expense Expectations 9:43 a.m. April 12, 2013 - benzinga.com
Durata Therapeutics Submits Marketing Authorization Application for Dalbavancin 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Durata Therapeutics Announces FDA's Acceptance for Priority Review of NDA for Dalvance(TM) (dalbavancin hydrochloride) 4:15 p.m. Nov. 26, 2013 - GlobeNewswire
Durata Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference 4:00 p.m. Nov. 15, 2013 - GlobeNewswire
MYGN, NPSP, DRTX and AMRI added to NASDAQ Active Stock Watch List at GSR 9:32 a.m. Nov. 6, 2013 - ACCESSWIRE
PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics 7:30 a.m. Nov. 6, 2013 - PR Newswire
Durata Therapeutics, Inc. Reports Third Quarter 2013 Financial Results 6:00 a.m. Nov. 6, 2013 - GlobeNewswire
Durata Therapeutics to Present at the 2013 Credit Suisse Healthcare Conference 7:30 a.m. Nov. 5, 2013 - GlobeNewswire
Durata Therapeutics to Announce Third Quarter 2013 Financial Results on November 6, 2013 6:30 a.m. Oct. 30, 2013 - GlobeNewswire
Durata Therapeutics Presents New Comprehensive Review of the Efficacy and Safety Data of Dalbavancin and New In Vitro Findings at IDWeek 2013(TM) 6:30 a.m. Oct. 2, 2013 - GlobeNewswire
Durata Therapeutics Announces NDA Submission for Dalbavancin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 1:49 p.m. Sept. 26, 2013 - GlobeNewswire
Dalbavancin Study Results to be Presented at IDWeek 2013 6:30 a.m. Sept. 25, 2013 - GlobeNewswire
Durata Therapeutics Presents New Pivotal Phase 3 Clinical Results and New In Vitro Data on Dalbavancin at ICAAC 2:13 p.m. Sept. 10, 2013 - GlobeNewswire
Dalbavancin Study Results to be Presented in Three Posters at the 53rd Annual ICAAC Meeting 2:04 p.m. Sept. 3, 2013 - GlobeNewswire
Durata Therapeutics, Inc. Reports Second Quarter 2013 Financial Results 6:30 a.m. Aug. 7, 2013 - GlobeNewswire
Durata Therapeutics to Present at the 2013 Wedbush Securities Life Sciences Management Access Conference 6:30 a.m. Aug. 6, 2013 - GlobeNewswire
Durata Therapeutics to Announce Second Quarter 2013 Financial Results on August 7, 2013 6:30 a.m. July 31, 2013 - GlobeNewswire
Durata Therapeutics to Present at JMP Securities Healthcare Conference 6:30 a.m. July 2, 2013 - GlobeNewswire
Durata Therapeutics to Present at Jefferies 2013 Global Healthcare Conference 6:30 a.m. May 29, 2013 - GlobeNewswire
Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors 12:45 p.m. May 16, 2013 - GlobeNewswire
Durata Therapeutics, Inc. Reports First Quarter 2013 Financial Results 6:00 a.m. May 9, 2013 - GlobeNewswire
7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
UPDATE: Wedbush Downgrades Durata Therapeutics as CBST/Hospira Litigation Overhang Looms 9:20 a.m. Dec. 2, 2013 - benzinga.com
Wedbush downgrades Durata Therapeutics to Neutral 8:02 a.m. Dec. 2, 2013 - Seeking Alpha
Durata Therapeutics (DRTX) in Focus: Stock Up 7.9% - Tale of the Tape 8:44 a.m. Nov. 29, 2013 - Zacks.com
2014 FDA Drug Approval Decision Calendar 8:00 a.m. Nov. 27, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:05 p.m. Nov. 22, 2013 - TheStreet.com
9 Biotechnology Stocks to Buy Now 6:45 a.m. Nov. 20, 2013 - InvestorPlace.com
UPDATE: Janney Capital Markets Initiates Coverage on Durata Therapeutics on Fundamentally Changing Antibiotic Treatment 7:38 a.m. Nov. 13, 2013 - benzinga.com
10-Q: DURATA THERAPEUTICS, INC. 6:47 a.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
8 Biotechnology Stocks to Sell Now 5:30 a.m. Oct. 3, 2013 - InvestorPlace.com
Durata Data on Dalbavancin Shows Primary Endpoints Met 5:33 a.m. Oct. 2, 2013 - benzinga.com
Durata Therapeutics Inc (DRTX) Enters Overbought Territory - Tale of the Tape 7:01 a.m. Sept. 12, 2013 - Zacks.com
10 Biotechnology Stocks to Sell Now 4:45 a.m. Sept. 4, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Sell Now 2:30 a.m. Aug. 21, 2013 - InvestorPlace.com
10-Q: DURATA THERAPEUTICS, INC. 7:08 a.m. Aug. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Durata Therapeutics' Novel Antibiotic Makes It A Prime Takeover For 2013 6:25 p.m. July 30, 2013 - Seeking Alpha
Buying Opportunity In Durata Therapeutics 12:04 p.m. June 28, 2013 - Seeking Alpha
10-Q: DURATA THERAPEUTICS, INC. 7:09 a.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Durata Announces Data from Phase I Trial of Dalbavancin 5:35 a.m. April 29, 2013 - benzinga.com
UPDATE: Wedbush Lowers PT on Durata Therapeutics on Revised 2013 Total Expense Expectations 9:43 a.m. April 12, 2013 - benzinga.com
Durata Therapeutics Submits Marketing Authorization Application for Dalbavancin 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Durata Therapeutics Announces FDA's Acceptance for Priority Review of NDA for Dalvance(TM) (dalbavancin hydrochloride) 4:15 p.m. Nov. 26, 2013 - GlobeNewswire
Durata Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference 4:00 p.m. Nov. 15, 2013 - GlobeNewswire
MYGN, NPSP, DRTX and AMRI added to NASDAQ Active Stock Watch List at GSR 9:32 a.m. Nov. 6, 2013 - ACCESSWIRE
PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics 7:30 a.m. Nov. 6, 2013 - PR Newswire
Durata Therapeutics, Inc. Reports Third Quarter 2013 Financial Results 6:00 a.m. Nov. 6, 2013 - GlobeNewswire
Durata Therapeutics to Present at the 2013 Credit Suisse Healthcare Conference 7:30 a.m. Nov. 5, 2013 - GlobeNewswire
Durata Therapeutics to Announce Third Quarter 2013 Financial Results on November 6, 2013 6:30 a.m. Oct. 30, 2013 - GlobeNewswire
Durata Therapeutics Presents New Comprehensive Review of the Efficacy and Safety Data of Dalbavancin and New In Vitro Findings at IDWeek 2013(TM) 6:30 a.m. Oct. 2, 2013 - GlobeNewswire
Durata Therapeutics Announces NDA Submission for Dalbavancin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 1:49 p.m. Sept. 26, 2013 - GlobeNewswire
Dalbavancin Study Results to be Presented at IDWeek 2013 6:30 a.m. Sept. 25, 2013 - GlobeNewswire
Durata Therapeutics Presents New Pivotal Phase 3 Clinical Results and New In Vitro Data on Dalbavancin at ICAAC 2:13 p.m. Sept. 10, 2013 - GlobeNewswire
Dalbavancin Study Results to be Presented in Three Posters at the 53rd Annual ICAAC Meeting 2:04 p.m. Sept. 3, 2013 - GlobeNewswire
Durata Therapeutics, Inc. Reports Second Quarter 2013 Financial Results 6:30 a.m. Aug. 7, 2013 - GlobeNewswire
Durata Therapeutics to Present at the 2013 Wedbush Securities Life Sciences Management Access Conference 6:30 a.m. Aug. 6, 2013 - GlobeNewswire
Durata Therapeutics to Announce Second Quarter 2013 Financial Results on August 7, 2013 6:30 a.m. July 31, 2013 - GlobeNewswire
Durata Therapeutics to Present at JMP Securities Healthcare Conference 6:30 a.m. July 2, 2013 - GlobeNewswire
Durata Therapeutics to Present at Jefferies 2013 Global Healthcare Conference 6:30 a.m. May 29, 2013 - GlobeNewswire
Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors 12:45 p.m. May 16, 2013 - GlobeNewswire
Durata Therapeutics, Inc. Reports First Quarter 2013 Financial Results 6:00 a.m. May 9, 2013 - GlobeNewswire
(0)
(0)